Routine annual meeting proxy notice with no contested items or activist involvement. Monitor for any dissident filings (DFAN14A) ahead of the July 14 meeting date. The $4M market cap and bearish analyst consensus suggest limited institutional interest — vote outcome is unlikely to move the stock.
Price Chart
Executive Summary
Decoy Therapeutics Inc. filed a DEFA14A (definitive additional proxy soliciting materials) providing notice of its 2026 Annual Meeting to be held virtually on July 14, 2026. The board recommends voting FOR all three proposals: election of three director nominees (Patricia Gauthier, Jonathan Lieber, Frederick E. Pierce), non-binding advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor for FY 2026. This is a routine management proxy solicitation with no dissident or activist campaign disclosed.
Key Financial Metrics
Key Facts
- Annual Meeting scheduled for July 14, 2026, held virtually
- Three director nominees: Patricia Gauthier, Jonathan Lieber, Frederick E. Pierce
- Board recommends FOR all three proposals: director election, say-on-pay, auditor ratification
- Ernst & Young LLP proposed as independent registered public accounting firm for FY ending Dec 31, 2026
- Record date and share counts not disclosed in this filing
- Market cap of $4M with 0% analyst bullish consensus (0 Strong Buy, 0 Buy, 3 Hold, 1 Sell, 2 Strong Sell)
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- No dissident or activist campaign identified — low risk of contested vote
- Micro-cap with $4M market cap and negative analyst sentiment (0% bullish) may face low shareholder turnout
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-256546 |
| Document: 0001193125-26-256546-index-headers.html | 0001193125-26-256546 |
| Document: 0001193125-26-256546-index.html | 0001193125-26-256546 |
| Document: 0001193125-26-256546.txt | 0001193125-26-256546 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | EFFECT | $1.17 $0.9100 | ▼ −22.22% | ▼ −22.08% | $1.03 (−11.97%) |
Oct 7, 2026 19d ago | S-1 | $1.52 $1.23 | ▲ +19.08% | ▲ +18.80% | $1.03 (+32.24%) |
Sep 23, 2026 4w ago | 8-K | $3.11 $1.86 | ▲ +40.35% | ▲ +39.94% | $1.03 (+66.88%) |
Aug 4, 2026 12w ago | DEFA14A | $4.19 $3.60 | ▼ −14.08% | ▼ −14.43% | $1.03 (−75.42%) |
Jul 20, 2026 14w ago | EFFECT | $5.31 $3.74 | ▼ −29.50% | ▼ −29.10% | $1.03 (−80.58%) |
Jun 29, 2026 17w ago | 8-K | $9.59 $7.25 | ▲ +24.40% | ▲ +25.79% | $1.03 (+89.26%) |
Jun 25, 2026 17w ago | EFFECT | $5.92 $7.62 | ▲ +28.76% | ▲ +27.20% | $1.03 (−82.60%) |
Jun 4, 2026 20w ago | DEFA14A | $6.71 $5.90 | ▼ −12.07% | ▼ −9.52% | $1.03 (−84.65%) |
Apr 30, 2026 25w ago | 10-K/A | $6.05 $6.01 | ▼ −0.66% | ▼ −2.39% | $1.03 (−82.98%) |
Apr 2, 2026 29w ago | 8-K | $5.80 $5.84 | ▲ +0.69% | ▼ −2.93% | $1.03 (−82.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers